| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0067 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |